Dennis M. Lanfear - 07 May 2025 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role: President & CEO, Director
Signature: /s/ Bryan McMichael, as Attorney-in-Fact for Dennis M. Lanfear
Issuer symbol: CHRS
Transactions as of: 07 May 2025
Net transactions value: $0
Form type: 4
Filing time: 09 May 2025, 17:58:02 UTC
Previous filing: 22 Jan 2025
Next filing: 22 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Lanfear Dennis M	President & CEO, Director	C/O COHERUS BIOSCIENCES, INC., 333 TWIN DOLPHIN DRIVE, SUITE 600, REDWOOD CITY	/s/ Bryan McMichael, as Attorney-in-Fact for Dennis M. Lanfear	09 May 2025	0001420822

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CHRS	Stock Option (Right to Buy)	Award	$0	+375,000		$0.000000	375,000	07 May 2025	Common Stock	375,000	$0.9462	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of May 7, 2025 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.